Rhenman & Partners Asset Management Ab Annexon, Inc. Transaction History
Rhenman & Partners Asset Management Ab
- $959 Million
- Q4 2024
A detailed history of Rhenman & Partners Asset Management Ab transactions in Annexon, Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 542,500 shares of ANNX stock, worth $1.52 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
542,500
Previous 560,000
3.13%
Holding current value
$1.52 Million
Previous $3.32 Million
16.05%
% of portfolio
0.29%
Previous 0.28%
Shares
7 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
98.2MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$20.8 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$19.7 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$17.7 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$15.8 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $134M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...